The combination of the CYP1B1 1294G allele and the SULT1A1 638A allele with modified ability to metabolize estrogens could increase the level of estrogen (i.e., 4-hydroxy-estradiol), which may finally result in a differential susceptibility to CRC. This evidence concerns the gene CYP1B1 and colorectal carcinoma.